Clinical Trial Update: Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice

View source ↗

Summary

This document reports on a completed clinical trial evaluating Symbicort Turbuhaler (formoterol/budesonide) as maintenance and reliever therapy for asthma in da…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort Turbuhaler (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED